Home » International Drug Policy Consortium (IDPC) » Page 13

International Drug Policy Consortium (IDPC)

Side Event: Implementing the United Nations Bangkok Rules: Women and Drug Policies

Organised by the Government of Canada, Centro de Estudios Legales y Sociales, the International Drug Policy Consortium, the Office of the High Commissioner for Human Rights, Penal Reform International, the Washington Office on Latin America and WHRIN   Introduction and Chairing by Marie Nougier, International Drug Policy Consortium Kristin McLeod (Canada): Canada is especially committed …

Read more

Side Event: Health Responses to the Opioid Poisoning Crisis: On-the-Ground Experiences and International Implications

Organized by Canada, and Canadian Association of People who Use Drugs, Canadian Drug Policy Coalition, Canadian HIV/AIDS Legal Network, Centre on Drug Policy Evaluation and International Drug Policy Consortium Fatal drug-related overdose is a pressing health crisis in North America. Highly potent synthetic opioids, including fentanyl and analogues, are increasingly present in the unregulated opioid …

Read more

Item 11. Follow-up to the special session of the General Assembly on the world drug problem held in 2016, including the seven thematic areas of the outcome document of the special session (Afternoon session)

Indonesia: Nearly 3 years have passed since UNGASS – we have been committed to advancing promotion of human rights. In addressing the drug problems whilst protecting human rights the government has provided funding for therapy programmes for drug users and special needs populations such as women and children. It is important that human rights are …

Read more

Side Event: Aligning data collection with UNGASS implementation & the Sustainable Development Goals: Recommendations for a review of the Annual Report Questionnaire.

Organized by the Governments of Canada, Mexico and Switzerland, the International Drug Policy Consortium, the Centre on Drug Policy Evaluation, and the Global Drug Policy Observatory of Swansea University Vera Strickler (Switzerland): To analyse key trends on the global drug market it is crucial to have reliable and empirical based indicators that are in line with …

Read more